Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats
about
Cell-based therapy for traumatic brain injuryCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsMesenchymal stem cells facilitate axon sorting, myelination, and functional recovery in paralyzed mice deficient in Schwann cell-derived laminin.Localization of bone marrow stromal cells to the injury site after intracerebral hemorrhage in rats.Angiogenesis, neurogenesis and brain recovery of function following injuryIntravenous mesenchymal stem cell therapy for traumatic brain injuryMesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblastsIntravenous transplantation of bone marrow mesenchymal stem cells promotes neural regeneration after traumatic brain injuryFusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells.Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model.The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: functional outcome and gene expression profile.Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow.Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of traumatic brain injuryFailure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat.Investigational agents for treatment of traumatic brain injuryTreatment of TBI with collagen scaffolds and human marrow stromal cells increases the expression of tissue plasminogen activator.Effects of neuroinflammation on the regenerative capacity of brain stem cellsJourney of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy.Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact InjuryStem cells in the umbilical cord.Treatment of traumatic brain injury in mice with marrow stromal cells.Cell therapies for traumatic brain injury.Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translationStem cell-based cellular replacement strategies following traumatic brain injury (TBI).Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells.Long-lasting benefits after treatment of traumatic brain injury (TBI) in rats with combination therapy of marrow stromal cells (MSCs) and simvastatinDelayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats.Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds.Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cellsStem cells in genetic myelin disorders.Neurorestorative treatments for traumatic brain injuryIn vitro Differentiation Potential of Mesenchymal Stem Cells.Mesenchymal stem cells for treatment of CNS injury.Functional assessment of long-term deficits in rodent models of traumatic brain injury.Improvements in biomaterial matrices for neural precursor cell transplantationTIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain Injury.Targeted delivery of AAV-transduced mesenchymal stromal cells to hepatic tissue for ex vivo gene therapy.Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences.
P2860
Q26998959-C0DADF3B-91FC-4327-AFAA-E39EE6B72901Q27026350-9E091F5E-A7EB-4112-B79D-85983D6EF888Q30501336-04A62A7D-B33E-41FB-8224-FFA303AD0886Q33709287-07EEDA4D-4C5B-4C56-ADCF-B2DC71A52BA8Q33718009-16EB0065-6789-4B88-8076-3752B6799BA0Q33929697-42A882DF-2789-45E6-8E85-49C141124488Q34053510-9C58E754-8CA8-4B35-ADDF-103C980D1F20Q34095987-7254F16D-61CB-4D45-B5EE-FC9254B53451Q34114518-97A6AE27-7943-4AAC-B6E4-1222D878739CQ34388516-B29A8F72-012C-479E-86DA-305A29BF8EFEQ34496587-40C39A00-6EE7-46F5-881E-812230338118Q34997877-038B43C2-EF74-457A-99D7-B0AC3940C184Q35134938-A9093D73-A027-44E1-93ED-097BDFAE7FE3Q35577615-CEBDA327-D1FA-4A8B-A8B5-4B344092D259Q35611476-5BBB9387-CD98-4009-AD2E-F356744A7CD3Q35768709-ECE8CA8A-8BF5-41F4-8606-ABBFAE4F73E6Q36055590-FDBAA127-DE5C-40F1-83DC-60707FD5D56FQ36055845-54D307CE-1D65-4C52-90B3-8F7639AB5930Q36111849-14612CB7-1C6B-4D6F-B8E4-F828E03426C1Q36260966-CD8211B2-B0D4-4B72-9CB9-CE6FC0732EBFQ36712808-ADF78F88-1A50-4715-88FE-9FB6AE25DD84Q36998922-0CA2C5BC-00AE-4E45-B16A-BA14DDF04A2AQ37040521-3066F771-6812-4DD7-B9DB-FA16C27A132BQ37040595-9104CD0D-5C21-46D6-883F-741E040D075EQ37157678-BF77E403-2520-43F7-B3CF-003C5B903DAFQ37251972-684ED4AA-46D5-4AE9-8046-2508C0ACAABCQ37286479-F3669E3F-FF0D-468E-ACBA-AE9906B0C4CEQ37332690-36604BC6-B92C-4CC3-889F-77674A5264B6Q37373325-1DA49627-8556-45AC-8B26-18E27FF26DA5Q37426965-BBD78112-384F-4AA8-9B18-5D9452AE5D47Q37747349-60DD9CD5-E2C5-476B-8D87-BB5F183AC899Q37814534-0AC74613-23FE-4DBF-BEB4-C9BE28463824Q37872602-BCFEFD16-5E0A-43C5-843A-51682F8B040CQ37883047-11BEC474-00D2-4C24-B2E8-C172778003F7Q38119246-0FB7CAA7-F08C-44B5-9057-F97625925830Q38521737-A1E837CA-E353-4113-8B22-65BDA921C381Q40615589-902402DC-636D-4A11-B7D5-B1A3FB6E05EEQ41176836-9EDF16E8-4A95-4E12-8C38-225581FCC4B3Q41486306-F6889EC3-D4F3-42B7-B69A-A3A856DE44B2Q41810795-2B1FF7B6-F012-4267-AF5D-9B54F883A414
P2860
Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human marrow stromal cell trea ...... traumatic brain injury in rats
@ast
Human marrow stromal cell trea ...... traumatic brain injury in rats
@en
type
label
Human marrow stromal cell trea ...... traumatic brain injury in rats
@ast
Human marrow stromal cell trea ...... traumatic brain injury in rats
@en
prefLabel
Human marrow stromal cell trea ...... traumatic brain injury in rats
@ast
Human marrow stromal cell trea ...... traumatic brain injury in rats
@en
P2093
P2860
P1433
P1476
Human marrow stromal cell trea ...... traumatic brain injury in rats
@en
P2093
Anton Goussev
Asim Mahmood
Changsheng Qu
P2860
P304
1026-31; discussion 1026-31
P356
10.1227/01.NEU.0000181369.76323.50
P407
P577
2005-11-01T00:00:00Z